American Society of Hematology

2018 ASH Meeting on Hematologic Malignancies

September 7-8, 2018
Fairmont Chicago, Millennium Park, Chicago, IL

Program Co-Chairs

John P. Leonard, MD

John P. Leonard, MD
Weill Cornell Medical College

S. Vincent Rajkumar, MD

S. Vincent Rajkumar, MD
Mayo Clinic

Gail Roboz, MD

Gail Roboz, MD
Weill Cornell Medical College

Program Planning Committee

  • Anjali Advani, MD, Cleveland Clinic
  • Jonathan W. Friedberg, MD, University of Rochester
  • Irene Ghobrial, MD, Dana-Farber Cancer Institute
  • Ruben A. Mesa, MD, UT Health San Antonio Cancer Center

Corporate Support

ASH thanks the following for their support of this meeting:

  • AbbVie, Inc.
  • Amgen, Inc.
  • AstraZeneca
  • Astellas Pharma
  • Celgene Corporation
  • Gilead Sciences, Inc.
  • Incyte Corporation
  • Jazz Pharmaceuticals
  • Merck & Co.
  • Novartis
  • Pfizer, Inc.
  • Pharmacyclics, An AbbVie Company
  • Takeda Oncology

Exhibitors

  • Amgen, Inc.
  • AstraZeneca
  • Bayer HealthCare Pharmaceuticals
  • BMS/Pfizer
  • Celgene Corporation
  • Daiichi Sankyo
  • Genentech
  • Gilead Sciences, Inc.
  • Incyte Corporation
  • Kite Pharma
  • Merck & Co.
  • Novartis
  • Pfizer, Inc.
  • SOPHiA Genetics
  • Takeda Oncology
  • TG Therapeutics
back to top